La Croix, Switzerland

Nicola Vannini

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignees: Ludwig Institute for Cancer Research Limited, Societe Des Produits Nestle S.a.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicola Vannini. Retrieved from https://idiyas.com/inventor/nicola-vannini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicola Vannini and His Work in T Cell Research

Introduction

Nicola Vannini is an inventor based in La Croix, Switzerland. His patent work concerns approaches to reducing T cell exhaustion, supporting T cell function, and boosting immunity.

Latest Patents

The supplied information lists one patent associated with Vannini: “Compositions and Methods for Increasing T Cell Function.” It describes agents for reducing T cell exhaustion, increasing T cell function, or boosting immunity. The listed agents include nicotinamide riboside, vitamin B12, urolithin, manganese, serine, glycine, arginine, asparagine, and combinations of two or more of these substances. The record attributes 1 patent to him.

Career Highlights

Vannini’s listed professional affiliations include Société des Produits Nestlé S.A. and Ludwig Institute for Cancer Research Limited. The patent’s focus connects his work with research into immune function and potential ways to support T cell activity.

Collaborations

The supplied information names Julie Laval and Caroline Monnard as Vannini’s coworkers. Their inclusion reflects professional connections associated with his work.

Conclusion

Nicola Vannini’s listed invention addresses potential methods for supporting T cell function and immunity, alongside career affiliations in industry and cancer research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…